Polycythemia vera (PV) is one of the three classic BCR/ABL-negative myeloproliferative neoplasm (MPN) and is characterized by an increased red blood cell mass induced by driver mutations in the JAK2 gene [1]. Here, JAK2 is linked to acquired polycythemia vera.